NEW YORK, September 6, 2017 /PRNewswire/ --
A market report by Ameri Research Inc. indicates that the global legal cannabis market was valued at $14.3
billion in 2016 and is projected to grow at a CAGR of 21.1% from 2017 to 2024. During the forecast period, the projected
demand of cannabis will continue to rise for both recreational and medical use with estimated global sales value to
reach $63.5 billion. The legal cannabis market is witnessing robust growth thanks to successful legalization and
decriminalization campaigns across North America and Europe. Ameri Research also explained that due to the complex
regulatory structure at the state level and federal level, the full potential of the market is not yet
realized. SinglePoint, Inc. (OTC: SING), Hemp, Inc. (OTC: HEMP), OWC Pharmaceutical Research Corp. (OTC: OWCP),
United Cannabis Corporation (OTC: CNAB), CV Sciences, Inc. (OTC: CVSI)
A research published by New Frontier Data shows how the pharmaceutical market will be influenced by medical cannabis. "The
United States constitutes 35% of the global pharmaceutical market, the largest market in the world, and a major driver of
the U.S. economy. It is one of many industries that will be impacted by the growth of the legal cannabis market and we are
already starting to see that trend in legal medical states where use of key prescription drugs is down by 11%. If cannabis were
to be adopted nationally, we would begin to see a trend of patients turning to medical cannabis as a substitute or complement to
pharmaceuticals," said Giadha Aguirre De Carcer, CEO & Founder, New Frontier Data.
SinglePoint, Inc. (OTC: SING) announced earlier today that the acquisition of Dr. FeelGood, a profitable cannabis
distribution company. Dr. FeelGood is a leading distribution company headquartered in Phoenix,
Arizona with expansion plans to add proprietary delivery and ordering technology application. Per the agreement terms,
SinglePoint will acquire fifty-one percent (51%) of the company in a combination of cash and stock, which will allow SinglePoint
to recognize all revenue. The acquisition will add an additional revenue stream to SinglePoint, solidifying the company's revenue
by acquisition strategy.
Dr. FeelGood represents the third acquisition of the year for SinglePoint. This move provides SinglePoint with additional
revenue as well as team members that have been actively working in the cannabis industry for many years. The founders of Dr.
FeelGood have already laid out a plan to develop a proprietary mobile application that will enhance the user experience and
streamline the company's operations. The companies look to release this app in the next 90 days, once completed they will be able
to license this technology to other distribution companies all over the United States.
SinglePoint CEO Greg Lambrecht states, "We are very excited for the success of this
acquisition. The acquisition of Dr. FeelGood is the third acquisition of the year. SinglePoints revenue has dramatically
increased, which through the acquisition of DIGS Hydro and Convectium has increased 378x compared to the 1st quarter of 2017.
SinglePoint is in a better position than it has ever been before. We are well capitalized to continue acquisitions and we are
optimistic to complete additional acquisitions and very optimistic to significantly increase the company revenue."
Dr. FeelGood has a wide variety of products that are distributed both B2B and B2C. Owners Scott
Riley and Jeff Clevenger have over 30 year's experience in building and scaling businesses
including the last six years running a cannabis distribution business. The two will continue to run day-to-day operations of Dr.
FeelGood with plans to expand the business and license the brand in additional states. The acquisition offer comes at a time when
the industry is rapidly expanding. In fact, reports suggest that the marijuana market in the United
States is growing faster than the smartphone and the tablet industry (PR News, 2017). As the market continues to expand
weekly, Dr. FeelGood has a positive looking future. According to Forbes (2016), polls show that more Americans are in support for
the legalizing of marijuana as it becomes continually popular for both recreation and medical reasons.
"This is a big moment for Dr. FeelGood. We know we can grow this business and with the capital and support of SinglePoint this
growth will happen quicker. The introductions they have put together already are immensely positive for us and once solidified
will exponentially increase our footprint in the market", states Scott Riley of Dr. FeeGood.
Simultaneously, SinglePoint and Dr. FeelGood are collaborating on a delivery platform. SinglePoint will utilize its location
based delivery application and add additional features such as a directory and ordering system to directly compete with Leafly
and WeedMaps. Dr. FeelGood already had plans to build the app and with SinglePoints head start the company will be able to
utilize the app much sooner and supply to parties that have expressed interest already."
Hemp, Inc. (OTC: HEMP) is a pioneer in the industrial hemp industry. On January 10,
2017, the company announced that its wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, in Spring Hope, NC, has signed a Letter of Intent with Mullen View Farms and one with John Finch Farms in
North Carolina. According to the signed LOI with Mullen View Farms, IHM will purchase 1,000
acres of raw hemp that is to be harvested at various locations throughout eastern North
Carolina, this year. The signed LOI with John Finch Farms stipulates IHM shall purchase 500 acres of raw hemp stock from
John Finch Farms. As with Mullen View Farms, the raw hemp is to be harvested at various locations throughout eastern North Carolina, this year.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), through its wholly-owned Israeli subsidiary, One World Cannabis Ltd.,
is conducting medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions
including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. On July 10, 2017, the
company announced that its subsidiary, One World Cannabis Ltd., has filed a patent application with the European Union Patent and
Trademark Office for its active cannabinoid-based psoriasis topical cream. OWC's strategy in seeking to fully protect its IP,
including the filing of this European patent application will enable the Company to accelerate its ongoing discussions and
negotiations regarding scientific, medical and commercial collaboration.
United Cannabis Corporation (OTCQB: CNAB) has long advocated the application of cannabinoids for medical applications
and is building a platform for designing targeted therapies to increase the quality of life for patients around the
world. The company announced that the United States Patent and Trademark Office has issued US Patent #9730911, granting
exclusive rights to its proprietary formulations based on compounds extracted from cannabis plant materials; more specifically,
the composition of matter pertaining to the use of phytocannabinoids, cannabinoids, and specific terpene profiles in liquid form.
This composition of matter patent provides protection for United Cannabis' proprietary formulations.
CV Sciences, Inc. (OTCQB: CVSI), focuses on drug development activities on products containing cannabidiol (CBD)
as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end
consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. The company recently announced that its
industry dominating brand of finished products, PlusCBD Oil™ will be exhibiting at Natural Products Expo East
on September 14-16, in Baltimore, Maryland. Produced by New Hope Network, Natural
Products Expo East is the leading trade show in the natural, organic and healthy products industry held on the East Coast,
attracting over 28,000 industry professionals and 1400 exhibits to the Baltimore Convention
Center.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts
on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For this release, FinancialBuzz.com has been compensated four thousand dollars for financial news dissemination and PR services by singlepoint inc. Our fees may be
either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination
thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on
or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments
for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site
or continue to post information about any companies the information contained herein is not intended to be used as the basis for
investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is
not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for
any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other
materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of
their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance,
and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound
by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please
visit: http://www.financialbuzz.com .
For further information:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com